Leukemia Clinical Trials in Los Angeles

Showing 661-680 of 1,416 trials

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00042003

To determine the safety and efficacy of decitabine in patients with Philadelphia chromosome-positive chronic myelogenous leukemia blastic phase that were previously treated with imatinib mesylate (STI 571) and became resistant/refractory or were found to be intolerant to the drug.

Chronic Myelogenous Leukemia

Astex Pharmaceuticals, Inc.40 participantsStarted Jul 2002

Duarte, California, United States • Escondido, California, United States • Los Angeles, California, United States +5 more locations

COMPLETEDNA< 1 mile

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

NCT01029353

This study will compare the effectiveness of two surgical procedures -laparotomy versus drainage - commonly used to treat necrotizing enterocolitis (NEC) or isolated intestinal perforations (IP) in extremely low birth weight infants (≤1,000 g). Infants diagnosed with NEC or IP requiring surgical intervention, will be recruited. Subjects will be randomized to receive either a laparotomy or peritoneal drainage. Primary outcome is impairment-free survival at 18-22 months corrected age.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more

NICHD Neonatal Research Network529 participantsStarted Jan 2010

Birmingham, Alabama, United States • Los Angeles, California, United States • Palo Alto, California, United States +19 more locations

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Leukemia Trials in Other Cities

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Improving Housing Outcomes for Homeless Veterans

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

The clonoSEQ® Watch Registry

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Other Conditions in Los Angeles